Róbert Hermann
Researcher Next ID · RN-038290
Researcher · Biochemistry, Genetics and Molecular Biology
Oslo, Norway
- Works count
- 520
- Citation count
- 20,979
- H-index
- 65
- i10-index
- 224
Research interests
Publications
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(19)30863-0
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30152-4
Relative predispositional effects of HLA class II DRB1‐DQB1 haplotypes and genotypes on type 1 diabetes: a meta‐analysis
Tissue Antigens · 2007 · https://doi.org/10.1111/j.1399-0039.2007.00867.x
Current projects
No projects listed.